Absolute Antibody

Specialists in antibody sequencing, engineering and recombinant manufacturing. Part of @AbsoluteBiotech.

[Absolute Antibody @AbsAntibody]

We’re thrilled to merge with Vector Laboratories! This partnership will enhance our offerings and drive innovation in antibody solutions for the life sciences community. Stay tuned for more updates.

[Vector Laboratories @VectorLabsUS]

Vector Laboratories today announced its intention to merge with @AbsoluteBiotech, a unified company of multiple antibody-centric brands. The transaction is a milestone in our commitment to better serve life science customers.

Read the full release: https://t.co/MoslVXK7qQ

[Absolute Antibody @AbsAntibody]

Visit us at PEGS Boston!

Stop by booth #400 to meet with our experts and discover how our custom services and catalog solutions can benefit your research. Catherine Bladen PhD, Micayla Bowman, PhD, Michael Fiebig, and Jason Shields will be on site. See you there!

[Absolute Antibody @AbsAntibody]

Need expert antibody services? We got you covered!

🧬 Sequencing – From hybridomas or purified proteins
⚙️ Engineering – Reformatting, humanization & bispecifics
🧪 Expression – Recombinant production at any scale
High-quality, tailored antibodies for your research.

[Absolute Antibody @AbsAntibody]

This 2024 study used Absolute Antibody's anti-TIGIT 1B4 to find that combination therapy targeting TIGIT and Tregs was effective at slowing ovarian cancer, the deadliest gynecological cancer. Full study: https://t.co/qqpxSxeHPf

[Absolute Antibody @AbsAntibody]

In a recent paper, Absolute Antibody’s Prometheus™ service was utilized to humanize a hybridoma-derived LGR5 antibody. The humanized variants were then used to develop bispecific t-cell engagers and antibody drug conjugates for further testing. https://t.co/nRR1qLbh5V

[Absolute Antibody @AbsAntibody]

Metapneumovirus cases are surging in China. To aid research, we engineered multiple anti-MPV antibody clones in a variety of formats for diverse applications.

Full list: https://t.co/M7J8KMDZFy

[Absolute Antibody @AbsAntibody]

From wild cats to house pets, the H5N1 Bird Flu is spreading. In WA, a sanctuary lost 20 big cats, and a house cat in OR died after eating raw food. To help research, we’ve engineered Cat IgG1 & IgM anti-H5N1 antibodies for diagnostics. Browse our catalog: https://t.co/4DLlipM6kW

[Absolute Antibody @AbsAntibody]

Transform your antibodies for clinical use with Prometheus™. Receive 10% off our in silico humanization service until the end of the year. Contact us for a quote: https://t.co/c3RrRy3yiP

[Absolute Antibody @AbsAntibody]

Antimicrobial resistance is on the rise and is estimated to reach $1 trillion USD in additional healthcare costs by the year 2050. One solution being explored for this public health crisis is the use of antibodies as antibacterial agents. Learn more: https://t.co/renjJoHDkA

[Absolute Antibody @AbsAntibody]

Our new article highlights the mechanisms of antibody-mediated cell depletion and how it revolutionizes cancer and autoimmune disease treatment.

Read the article here: https://t.co/w40KEu8d2Z

#AntibodyTherapeutics

[Absolute Antibody @AbsAntibody]

Our team, Catherine Bladen PhD and Alex Scott, will be at #PEGSEurope next week in Barcelona, Spain. We invite you to visit us at booth #1310 to learn more about our custom services and explore our extensive antibody reagent catalog.

[Absolute Antibody @AbsAntibody]

Absolute Antibody is excited to announce that we have joined the PACE Delivery Partner Network to offer our recombinant antibody expertise to researchers studying antimicrobial resistance.

Learn more here: https://t.co/1WpLUV94zA

[Absolute Antibody @AbsAntibody]

DON’T MISS OUT: Join Absolute Antibody and Dr. Lucia Lupica Spagnolo tomorrow as we discuss the process of humanizing antibodies from murine and non-murine origins.

Register here: https://t.co/PupwFc3Mbg

[Absolute Antibody @AbsAntibody]

Join us Oct. 2 for a live webinar with Dr. Lucia Lupica-Spagnolo as she discusses the Prometheus 2.0™ antibody humanization platform and how it has been optimized to increase expression titers and decrease aggregation of humanized antibodies: https://t.co/PupwFc3Mbg

[Absolute Antibody @AbsAntibody]

A new mAb has entered human clinical trials targeting Nipah, a virus passed from bats to humans that kills up to 75% of infected people. Recombinant anti-Nipah mAbs: https://t.co/KqRk7HXQTU

More info: https://t.co/Fu7BL6rma3

[Absolute Antibody @AbsAntibody]

Our Chief Scientific Officer Michael Fiebig will be speaking at an online workshop hosted by the @PCRM on Sept. 11th. Learn more: https://t.co/HOJ9YditMI

[Absolute Antibody @AbsAntibody]

A new study uses our recombinant anti-DNA-RNA hybrid antibodies to shed light on the roles ATRX/DAXX plays in genomic stability and even cancer. This and more in our article: https://t.co/FiiMBo8oBg

[Absolute Antibody @AbsAntibody]

Our new article reviews how blocking antibodies are used as cancer therapeutics and how antibody engineering enables even more research possibilities.
Article link: https://t.co/YOghAbbAQD

[Absolute Antibody @AbsAntibody]

An excellent overview of Fc "silencing" methods used in clinical antibodies. It is clear that many approaches still retain Fc-mediated activity - especially those in the LALA-family. Contact us if you want to work with the truly silent STR-platform for silencing human IgG1.

[Absolute Antibody @AbsAntibody]

Mpox has been declared a public health emergency. Recombinant engineered antibodies can help develop better vaccines and diagnostics. #Mpox

Read more here: https://t.co/E948fCSdXV

[Absolute Antibody @AbsAntibody]

New Case Study: Engineering Chimeric Antibodies to Study IgG Hexamerization. Researchers at UCSF used antibody engineering to determine that assembly of IgG alloantibody multimers is a critical event initiating complement-dependent lung injury responses. https://t.co/Oqs4fI1aZR